Is Trevena, Inc. (TRVN) a Buy, Sell, or Hold?
OTC : TRVN
Trevena, Inc. — Insider Trades
$0.001 USD
-$0.01 (-90.99%)
- Volume
- 102
- Average Volume
- 149.98
- Market Capitalization
- $864
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.93
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.66
Insider Activity Summary (Last 12 Months)
Insiders Buying
16
Insiders Selling
36
Amount of Insider Selling
$49609
TRVN Insider Buying/Selling by Quarter
TRVN Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Sutton Katrine | officer: VP, Finance | 2024-11-26 | 0 | 2024-12-06 | |
| Sutton Katrine | officer: VP, Finance | 2024-11-26 | 568.75 | 2024-12-06 | |
| Demitrack Mark | officer: Acting CMO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Demitrack Mark | officer: Acting CMO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Demitrack Mark | officer: Acting CMO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Demitrack Mark | officer: Acting CMO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Demitrack Mark | officer: Acting CMO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Shin Barry | officer: Acting COO and CFO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Shin Barry | officer: Acting COO and CFO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Shin Barry | officer: Acting COO and CFO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Shin Barry | officer: Acting COO and CFO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Shin Barry | officer: Acting COO and CFO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Bourdow Carrie L. | director, officer: Acting CEO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Bourdow Carrie L. | director, officer: Acting CEO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Bourdow Carrie L. | director, officer: Acting CEO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Bourdow Carrie L. | director, officer: Acting CEO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Bourdow Carrie L. | director, officer: Acting CEO | 2024-10-08 | F-InKind | 1.47 | 2024-10-10 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2024-09-14 | F-InKind | 5.95 | 2024-09-17 |
| Shin Barry | officer: SVP, CFO | 2024-09-14 | F-InKind | 5.95 | 2024-09-17 |
| Braunstein Scott | director | 2024-06-13 | A-Award | 0.4 | 2024-06-17 |
| Yanni Barbara | director | 2024-06-13 | A-Award | 0.4 | 2024-06-14 |
| Nunn Jason Raleigh | director | 2024-06-13 | A-Award | 0.4 | 2024-06-14 |
| CORRIGAN MARK | director | 2024-06-13 | A-Award | 0.4 | 2024-06-14 |
| Phillips Anne M. | director | 2024-06-13 | A-Award | 0.4 | 2024-06-14 |
| Johnson Marvin | director | 2024-06-13 | A-Award | 0.4 | 2024-06-14 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2023-12-14 | F-InKind | 0.61 | 2023-12-15 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Bourdow Carrie L. | officer: President & CEO | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Bourdow Carrie L. | officer: President & CEO | 2023-12-14 | F-InKind | 0.61 | 2023-12-15 |
| Bourdow Carrie L. | officer: President & CEO | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Shin Barry | officer: SVP, CFO | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Shin Barry | officer: SVP, CFO | 2023-12-14 | F-InKind | 0.61 | 2023-12-15 |
| Shin Barry | officer: SVP, CFO | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2023-12-14 | F-InKind | 0.61 | 2023-12-15 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2023-12-14 | F-InKind | 0.61 | 2023-12-15 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2023-12-14 | A-Award | 0.61 | 2023-12-15 |
| Bourdow Carrie L. | officer: President & CEO | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Bourdow Carrie L. | officer: President & CEO | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Bourdow Carrie L. | officer: President & CEO | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Shin Barry | officer: SVP, CFO | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Shin Barry | officer: SVP, CFO | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Shin Barry | officer: SVP, CFO | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2023-12-02 | F-InKind | 0.59 | 2023-12-05 |
| Shin Barry | officer: SVP, CFO | 2023-09-14 | F-InKind | 0.7 | 2023-09-18 |
| CORRIGAN MARK | director | 2023-07-18 | A-Award | 0.93 | 2023-07-20 |
| CORRIGAN MARK | director | 2023-07-18 | 0 | 2023-07-20 | |
| Shin Barry | officer: SVP, CFO | 2023-06-26 | F-InKind | 0.84 | 2023-06-28 |
| Johnson Marvin | director | 2023-06-15 | A-Award | 1.04 | 2023-06-20 |
| Yanni Barbara | director | 2023-06-15 | A-Award | 1.04 | 2023-06-20 |
| Phillips Anne M. | director | 2023-06-15 | A-Award | 1.04 | 2023-06-20 |
| Nunn Jason Raleigh | director | 2023-06-15 | A-Award | 1.04 | 2023-06-20 |
| DOUGHERTY MICHAEL R | director | 2023-06-15 | A-Award | 1.04 | 2023-06-20 |
| MOULDER LEON O JR | director | 2023-06-15 | A-Award | 1.04 | 2023-06-20 |
| Braunstein Scott | director | 2023-06-15 | A-Award | 1.04 | 2023-06-20 |
| Shin Barry | officer: SVP, CFO | 2023-01-06 | A-Award | 0 | 2023-01-06 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2023-01-06 | A-Award | 0 | 2023-01-06 |
| Bourdow Carrie L. | officer: President & CEO | 2023-01-06 | A-Award | 0 | 2023-01-06 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2023-01-06 | A-Award | 0 | 2023-01-06 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2023-01-06 | A-Award | 0 | 2023-01-06 |
| Bourdow Carrie L. | officer: President & CEO | 2022-12-17 | F-InKind | 1.55 | 2022-12-20 |
| Shin Barry | officer: SVP, CFO | 2022-12-17 | F-InKind | 1.55 | 2022-12-20 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2022-12-17 | F-InKind | 1.55 | 2022-12-20 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2022-12-17 | F-InKind | 1.55 | 2022-12-20 |
| Bourdow Carrie L. | officer: President & CEO | 2022-12-02 | F-InKind | 3.42 | 2022-12-06 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2022-12-02 | F-InKind | 3.42 | 2022-12-06 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2022-12-02 | F-InKind | 3.42 | 2022-12-06 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2022-12-02 | F-InKind | 3.42 | 2022-12-06 |
| Shin Barry | officer: SVP, CFO | 2022-12-02 | F-InKind | 3.42 | 2022-12-06 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2022-11-10 | F-InKind | 2.47 | 2022-11-15 |
| Shin Barry | officer: SVP, CFO | 2022-06-28 | S-Sale | 0.41 | 2022-06-29 |
| DOUGHERTY MICHAEL R | director | 2022-06-09 | A-Award | 0.43 | 2022-06-13 |
| DOUGHERTY MICHAEL R | director: | 2022-06-09 | A-Award | 0 | 2022-06-13 |
| Johnson Marvin | director: | 2022-06-09 | A-Award | 0 | 2022-06-13 |
| MOULDER LEON O JR | director | 2022-06-09 | A-Award | 0.43 | 2022-06-13 |
| MOULDER LEON O JR | director: | 2022-06-09 | A-Award | 0 | 2022-06-13 |
| Nunn Jason Raleigh | director: | 2022-06-09 | A-Award | 0 | 2022-06-13 |
| Phillips Anne M. | director: | 2022-06-09 | A-Award | 0 | 2022-06-13 |
| Yanni Barbara | director: | 2022-06-09 | A-Award | 0 | 2022-06-13 |
| Braunstein Scott | director | 2022-06-09 | A-Award | 0.43 | 2022-06-13 |
| Braunstein Scott | director: | 2022-06-09 | A-Award | 0 | 2022-06-13 |
| Bourdow Carrie L. | director, officer: President & CEO | 2021-12-17 | F-InKind | 0.7 | 2021-12-21 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2021-12-17 | F-InKind | 0.7 | 2021-12-21 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2021-12-17 | F-InKind | 0.7 | 2021-12-21 |
| Shin Barry | officer: SVP, CFO | 2021-12-17 | F-InKind | 0.7 | 2021-12-21 |
| Demitrack Mark | officer: SVP, Chief Medical Officer | 2021-12-06 | F-InKind | 0.65 | 2021-12-08 |
| Yoder Robert T | officer: SVP, Chief Business Officer | 2021-12-06 | F-InKind | 0.65 | 2021-12-08 |
| Shin Barry | officer: SVP, CFO & CCO | 2021-12-06 | F-InKind | 0.65 | 2021-12-08 |
| Bourdow Carrie L. | director, officer: President & CEO | 2021-12-06 | F-InKind | 0.65 | 2021-12-08 |
| Drake Patricia M. | officer: SVP, Chief Commercial Officer | 2021-12-02 | A-Award | 0 | 2021-12-03 |